Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Podcasts

Listen to the latest oncology news from international experts

Updates in immunotherapy for GU cancer

In this podcast, we highlight some of the latest updates in the use of immunotherapy to treat genitourinary cancer. This week we will be joined by Camillo Porta, MD, University of Bari Aldo Moro, Bari, Italy, Joaquim Bellmunt, MD, PhD, Dana-Farber Cancer Institute, Boston, MA,  Arlene Siefker-Radtke, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Maria Bourlon, MD, MS, El Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

We will cover findings from key trials, including CHECKMATE 901 on nivolumab with gemcitabine and cisplatin for metastatic urothelial carcinoma; JAVELIN Renal 101 comparing avelumab plus axitinib with sunitinib for advanced renal cell carcinoma; a JAVELIN Bladder 100 post hoc analysis on avelumab for first-line maintenance in advanced urothelial carcinoma; TROPiCS-04 on sacituzumab govitecan in advanced urothelial carcinoma; and CheckMate 67T comparing subcutaneous and intravenous nivolumab for advanced renal cell carcinoma

For other GU cancer news, be sure to visit our dedicated GU Cancer Channel.

Subscribe to our podcasts on Apple Podcasts, Podbean, and Spotify and join the conversation via X (formerly Twitter) @VJOncology. For more updates in the field, visit vjoncology.com.

Date: 23rd August 2024

Apple Podcasts | RSS

The content of VJOncology is intended for healthcare professionals